VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AVAH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AVAHAveanna Healthcare Holdings Inc.
$12.79$2.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAVAHBalance Sheet

Aveanna Healthcare Holdings Inc. (AVAH) Balance Sheet

8Y historyFree accessUpdated daily

The company maintains a highly leveraged capital structure with $1.5B in total debt and a debt-to-equity ratio of 5.24, while goodwill of $1.3B constitutes over 450% of total equity, highlighting significant concentration risk.

Income StatementBalance SheetCash FlowRatios

AVAH Balance Sheet

Annual statement

AVAH Balance Sheet

Aveanna Healthcare Holdings Inc. (AVAH) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMJan'26Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets478.09M560.23M392.67M314.89M269.75M279.21M340.64M186.34M214.93M
Cash & Short-Term Investments97.2M193.26M84.29M43.94M19.22M30.49M137.34M3.33M8M
Cash Only97.2M193.26M84.29M43.94M19.22M30.49M137.34M3.33M8M
Short-Term Investments000000000
Accounts Receivable340.99M313.36M277.66M245.81M225.63M225.29M180.88M164.3M182.45M
Days Sales Outstanding45.8447.0150.0647.3446.0748.9944.1643.3353.12
Inventory000000000
Days Inventory Outstanding---------
Other Current Assets17.68M29.92M13.25M9.45M9.81M9.2M11.34M8.56M14.99M
Total Non-Current Assets1.63B1.47B1.27B1.3B1.44B2.06B1.5B1.39B1.34B
Property, Plant & Equipment56.88M55.69M58.65M70.05M77.35M83.37M78.87M80.47M27.25M
Fixed Asset Turnover46.97x43.69x34.52x27.06x23.11x20.14x18.96x17.20x46.00x
Goodwill1.28B1.12B1.05B1.05B1.16B1.84B1.32B1.23B1.23B
Intangible Assets99.82M92.56M89.57M94.01M95.86M102.85M73.57M54.3M53.34M
Long-Term Investments112.64M37.51M60.63M74.81M000021.74M
Other Non-Current Assets58.8M8.21M7.33M4.67M109.11M33.36M31.62M30.35M8.27M
Total Assets2.11B2.03B1.66B1.61B1.71B2.33B1.84B1.58B1.55B
Asset Turnover1.31x1.20x1.22x1.17x1.04x0.72x0.81x0.88x0.81x
Asset Growth %72.59%21.78%3.13%-5.77%-26.67%26.59%16.83%1.77%-
Total Current Liabilities411.32M424.46M402.17M354.76M326.5M344.83M260.41M168.54M198.36M
Accounts Payable32.41M31.97M36.44M30.13M44.62M52.62M56.67M66.42M0
Days Payables Outstanding6.487.179.578.4613.1916.9119.8825.13-
Short-Term Debt178.25M184.43M183.1M168.16M15.38M13.71M12.78M10.09M9.4M
Deferred Revenue (Current)00000029.44M0-37.99M
Other Current Liabilities85.98M29.73M38.65M42.24M181.26M174.37M54.89M20.74M113.97M
Current Ratio1.16x1.32x0.98x0.89x0.83x0.81x1.31x1.11x1.08x
Quick Ratio1.16x1.32x0.98x0.89x0.83x0.81x1.31x1.11x1.08x
Cash Conversion Cycle39.35--------
Total Non-Current Liabilities1.41B1.41B1.38B1.39B1.39B1.35B1.32B1.14B1.01B
Long-Term Debt1.28B1.29B1.27B1.28B1.28B1.23B1.16B1.02B954.73M
Capital Lease Obligations104.59M27.41M31.72M39.82M45.82M44.68M40.25M41.22M0
Deferred Tax Liabilities19.84M13.34M5.89M4.86M3.84M3.05M27.41M1.75M1.75M
Other Non-Current Liabilities96.45M78.67M74.05M64.64M58.69M77.34M85.28M78.42M52.86M
Total Liabilities1.82B1.83B1.79B1.74B1.72B1.7B1.58B1.31B1.21B
Total Debt1.51B1.51B1.5B1.5B1.36B1.3B1.23B1.08B952.44M
Net Debt1.41B1.32B1.42B1.46B1.34B1.27B1.09B1.08B944.44M
Debt / Equity5.24x7.79x---2.04x4.60x3.98x2.76x
Debt / EBITDA4.86x5.24x8.79x39.28x--45.94x16.37x18.69x
Net Debt / EBITDA4.54x4.57x8.29x38.13x--40.81x16.32x18.53x
Interest Coverage2.24x1.79x1.00x0.06x-5.23x-0.77x0.38x0.19x0.34x
Total Equity287.28M194.46M-122.09M-127.44M-4.17M637.95M267.17M270.94M344.99M
Equity Growth %3359.82%259.28%4.19%-2952.34%-100.65%138.78%-1.39%-21.46%-
Book Value per Share1.280.90-0.63-0.67-0.023.451.441.461.91
Total Shareholders' Equity287.28M194.46M-122.09M-127.44M-4.17M637.95M267.17M270.94M344.99M
Common Stock2.18M2.11M1.93M1.91M1.89M1.85M1.42M1.37M66K
Retained Earnings-1.08B-1.16B-1.38B-1.37B-1.24B-574.68M-457.63M-400.58M-323.83M
Treasury Stock000000000
Accumulated OCI001.46M2.13M00000
Minority Interest000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Elevated leverage and goodwill concentration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Easing from Deep Deficit

Aveanna's balance sheet has undergone a dramatic transformation, with equity swinging from a negative $134.1M in 2024Q1 to a positive $287.3M in 2026Q2, a shift primarily driven by retained earnings accumulation and likely equity issuances.

The company has successfully reversed a multi-quarter trend of negative equity, which is a critical inflection point for a highly leveraged firm. This improvement, however, appears to be driven more by accounting adjustments and capital raises than by the generation of substantial retained earnings, as the cumulative deficit remains deeply negative at $1.1B. The trajectory suggests a stabilization of the capital structure, but the underlying profitability required to sustain this positive equity position is still being established.

Persistent High Leverage Constrains Flexibility

Despite the equity improvement, the company maintains a substantial $1.5B debt load as of 2026Q2, resulting in a debt-to-equity ratio of 5.24, which remains significantly elevated compared to peers like Addus HomeCare (0.19).

The leverage profile, while improved from the extreme levels seen in 2025Q3, continues to represent a significant financial constraint. The high debt level relative to the company's asset base suggests that a substantial portion of operating cash flow is likely dedicated to interest and principal servicing, limiting financial flexibility for organic investment or weathering operational setbacks. This capital structure appears to be a legacy of the company's aggressive acquisition strategy and warrants close monitoring for refinancing risk.

Goodwill Dominance Signals Acquisition-Heavy Model

Goodwill and intangible assets constitute approximately 62% of total assets at $1.3B in 2026Q2, highlighting the company's reliance on acquisitions for growth and creating significant impairment risk if operational performance falters.

The asset mix is heavily skewed toward intangible value, with tangible assets like PPE representing a minimal fraction of the balance sheet. This structure is typical of a roll-up strategy but introduces substantial risk; any deterioration in the performance of acquired units could trigger material goodwill impairments that would further erode the already thin equity base. The quality of these intangible assets is directly tied to the company's ability to integrate and grow the acquired pediatric and home health operations.

Cash Position Volatile but Adequate for Operations

The current ratio has improved to 1.16 in 2026Q2 from a low of 0.88 in 2024Q1, and the cash position stands at $97.2M, providing a modest but necessary buffer for working capital needs in a labor-intensive business.

Liquidity has strengthened materially over the past two years, moving from a position of potential short-term stress to one of adequate coverage. However, the cash balance is highly volatile quarter-to-quarter, as seen in the drop from $189.3M in 2026Q1 to $97.2M in 2026Q2, which likely reflects the timing of acquisition payments and working capital swings. This volatility suggests that while the company can meet its immediate obligations, its liquidity position is not a fortress and is sensitive to operational and investment cash flow timing.

Goodwill Impairment as the Hidden Equity Risk

The $1.3B in goodwill represents over 450% of the company's total equity, meaning a moderate impairment event of just 25% could erase the entire equity base and re-inscribe a negative net worth position.

This is the most significant non-obvious risk on the balance sheet. The headline equity improvement is fragile because it is overwhelmingly offset by the value of acquired intangibles. Given the company's history of acquisitions and the operational complexity of integrating different state Medicaid programs, the risk of an impairment charge is non-trivial. Investors should monitor segment-level performance, particularly in the Home Health & Hospice segment, as underperformance there could be the catalyst for such a write-down.

AVAH — Frequently Asked Questions

Quick answers to the most common questions about buying AVAH stock.

What are the total assets of Aveanna Healthcare Holdings Inc. (AVAH)?

As of 2025, Aveanna Healthcare Holdings Inc. (AVAH) had total assets of $2.03B including $560.2M in current assets.

How much debt does Aveanna Healthcare Holdings Inc. (AVAH) have?

Aveanna Healthcare Holdings Inc. (AVAH) carries total debt of $1.51B, offset by $193.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Aveanna Healthcare Holdings Inc.?

Aveanna Healthcare Holdings Inc. (AVAH) has total shareholders' equity (book value) of $194.5M ($0.90 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Aveanna Healthcare Holdings Inc.'s current ratio and liquidity?

Aveanna Healthcare Holdings Inc. (AVAH) reported a current ratio of 1.32x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.